These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 3375215

  • 1. [Phenotype of isoniazid acetylation and tolerance of antitubercular drugs].
    Gontsa FT, Savina LA, Tsurkan VP, Kovalenko IP.
    Probl Tuberk; 1988; (2):35-8. PubMed ID: 3375215
    [No Abstract] [Full Text] [Related]

  • 2. [Type of isoniazid (INH) acetylation determined in tuberculosis patients treated at the Institute of Tuberculosis and Lung Diseases in Warsaw during the years 1990-1997].
    Augustynowicz-Kopeć E, Zwolska Z.
    Pneumonol Alergol Pol; 2002; 70(3-4):180-92. PubMed ID: 12271965
    [Abstract] [Full Text] [Related]

  • 3. Importance of acetylation and oxidation in inactivation of isonicotinic acid hydrazide preparations.
    Smirnov GA.
    Fed Proc Transl Suppl; 1966; 25(1):72-6. PubMed ID: 5322111
    [No Abstract] [Full Text] [Related]

  • 4. Comparison between serum and urinary sulphadimidine acetylation as predictors of isoniazid acetylator status in patients with pulmonary tuberculosis.
    Singh SP, Pande JN, Khilnani GC, Kailash S.
    Indian J Chest Dis Allied Sci; 1996; 38(1):5-11. PubMed ID: 16892742
    [Abstract] [Full Text] [Related]

  • 5. [Inactivation of the HINA preparations and certain indicators of the detoxicating function of the liver in patients with pulmonary tuberculosis].
    Fitsaĭ AV.
    Probl Tuberk; 1973; 51(6):83-4. PubMed ID: 4764137
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Population screening for isoniazid acetylator phenotype.
    Seifart HI, Parkin DP, Botha FJ, Donald PR, Van Der Walt BJ.
    Pharmacoepidemiol Drug Saf; 2001; 10(2):127-34. PubMed ID: 11499851
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Intermittent method of treatment of patients with pulmonary tuberculosis showing poor tolerance of antitubercular agents].
    Sushkin AG.
    Vrach Delo; 1973 Nov; 11():94-7. PubMed ID: 4786944
    [No Abstract] [Full Text] [Related]

  • 16. Complete sequencing of a genetic polymorphism in NAT2 in the Korean population.
    Lee SY, Lee KA, Ki CS, Kwon OJ, Kim HJ, Chung MP, Suh GY, Kim JW.
    Clin Chem; 2002 May; 48(5):775-7. PubMed ID: 11978608
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Antitubercular agents: pharmacogenetic factors in the development of adverse effects].
    Ligueros M, Saavedra H, Neira S, Cruz-Coke R, Saavedra A, Kramer V, Gelman M, Nuñez A, Prieto JC.
    Rev Med Chil; 1990 Jul; 118(7):727-35. PubMed ID: 2131519
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.